A Pilot Study: Randomised Sham-Controlled Trial of Electroacupuncture for Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Patients Receiving Taxane for Early-Breast Cancer

被引：0
|
作者：
Choi, Victoria [1 ]
Park, Susanna B. [2 ]
Kumar, Sanjeev [1 ]
Heller, Gillian [3 ]
Lacey, Judith [1 ]
Grimison, Peter [1 ]
机构：
[1] Chris Obrien Lifehouse, Camperdown, NSW, Australia
[2] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia
[3] Univ Sydney, NHMRCClin Trials Ctr, Sydney, NSW, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：34 / 35
页数：2
相关论文
共 50 条
  • [1] Pilot sham-controlled randomised trial of electroacupuncture for chemotherapy-induced peripheral neuropathy (CIPN) in patients receiving taxanes for early breast cancer
    Choi, Victoria
    Park, Susanna B.
    Lacey, Judith
    Kumar, Sanjeev
    Heller, Gillian
    Grimison, Peter
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 249 - 250
  • [2] Electroacupuncture use for treatment of taxane-induced peripheral neuropathy in patients with breast cancer: protocol for a pilot, randomised, blinded, sham-controlled trial (EA for CIPN)
    Choi, Victoria
    Park, Susanna B.
    Lacey, Judith
    Kumar, Sanjeev
    Heller, Gillian
    Grimison, Peter
    BMJ OPEN, 2024, 14 (01):
  • [3] Acupuncture Relieved Chemotherapy-Induced Peripheral Neuropathy in Patients with Breast Cancer: A Pilot Randomized Sham-Controlled Trial
    Huang, Chien-Chen
    Ho, Tsung-Jung
    Ho, Hsin-Yueh
    Chen, Pei-Yu
    Tu, Cheng-Hao
    Huang, Yu-Chuen
    Lee, Yu-Chen
    Sun, Mao-Feng
    Chen, Yi-Hung
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (16)
  • [4] A Pilot Randomized Sham-Controlled Trial of MC5-A Scrambler Therapy in the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN)
    Smith, Thomas J.
    Razzak, A. Rab
    Blackford, Amanda L.
    Ensminger, Jennifer
    Saiki, Catherine
    Longo-Schoberlein, Denise
    Loprinzi, Charles L.
    JOURNAL OF PALLIATIVE CARE, 2020, 35 (01) : 53 - 58
  • [5] A pilot randomized sham-controlled trial of MC5-A scrambler therapy in the treatment of chronic chemotherapy-induced peripheral neuropathy (CIPN).
    Smith, Thomas J.
    Razzak, A. Rab
    Blackford, Amanda L.
    Ensminger, Jennifer
    Saiki, Catherine
    Loprinzi, Charles L.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] The effect of photobiomodulation on chemotherapy-induced peripheral neuropathy: A randomized, sham-controlled clinical trial
    Argenta, Peter A.
    Baliman, Karla V.
    Geller, Melissa A.
    Carson, Linda F.
    Ghebre, Rahel
    Mullany, Sally A.
    Teoh, Deanna G. K.
    Winterhoff, Boris J. N.
    Rivard, Colleen L.
    Erickson, Britt K.
    GYNECOLOGIC ONCOLOGY, 2017, 144 (01) : 159 - 166
  • [7] Topical menthol for chemotherapy-induced peripheral neuropathy: a randomised controlled trial in breast cancer
    Ozdemir, Deniz
    Arslan, Selda
    Artac, Mehmet
    Karaarslan, Fatih
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2024,
  • [8] Acupuncture for chemotherapy-induced peripheral neuropathy in breast cancer patients: Pilot trial
    Park, S. H.
    Jeong, Y. J.
    Kwak, M. A.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S150 - S150
  • [9] Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer
    Greenlee, Heather
    Crew, Katherine D.
    Capodice, Jillian
    Awad, Danielle
    Buono, Donna
    Shi, Zaixing
    Jeffres, Anne
    Wyse, Sharon
    Whitman, Wendy
    Trivedi, Meghna S.
    Kalinsky, Kevin
    Hershman, Dawn L.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (03) : 453 - 464
  • [10] Acupuncture for chemotherapy-induced peripheral neuropathy: a randomised controlled pilot study
    D'Alessandro, Eduardo Guilherme
    Nebuloni Nagy, Daniela Ribeiro
    Moran de Brito, Christina May
    Marinho Almeida, Elisangela Pinto
    Battistella, Linamara Rizzo
    Cecatto, Rebeca Boltes
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2022, 12 (01) : 64 - 72
12345